We estimated the expression of MDM2 in three NSCLC cell lines harboring EGFR sensitive mutations, including HCC2279, NCI-H3255 and HCC4006 cell lines and HCC2279 cell line were eventually selected for subsequent experiments. This evidence concerns the gene EGFR and non-small cell lung carcinoma.